Results 171 to 180 of about 220,392 (312)

Development of immunocompetent models for primary and metastatic ER+ breast cancer

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This study explores syngeneic, immunocompetent models of ER+ breast cancer in 129S6/SvEv mice, using trackable tumor cells to model both primary tumors and metastasis. The models show promise, while also revealing limitations for studying advanced disease and immune interactions.
Devon M. Bull   +5 more
wiley   +1 more source

Risk factors for ductal carcinoma in situ: comparisons with invasive breast cancer. [PDF]

open access: yesBreast Cancer Res
Abe JV   +6 more
europepmc   +1 more source

Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome

open access: green, 2020
Kara A. Lombardo   +10 more
openalex   +2 more sources

Hematoma Interleukin‐1 Receptor Antagonist Concentrations Predict Long‐Term Outcome in Acute Human Intracerebral Hemorrhage

open access: yesAnnals of Neurology, EarlyView.
Objectives The interleukin (IL)‐1, IL‐6, and C‐reactive protein (CRP) pathway is central to the immune response after intracerebral hemorrhage (ICH). We tested for associations between hematoma and plasma cytokine concentrations and patient outcomes in Minimally Invasive Surgery Plus Rt‐PA for ICH Evacuation Phase III (MISTIE III) participants ...
Adrian R. Parry‐Jones   +54 more
wiley   +1 more source

Additional file 8: Figure S5. of Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion

open access: green, 2015
Hanan S. Elsarraj   +25 more
openalex   +1 more source

Home - About - Disclaimer - Privacy